In conventional chondrosarcoma, B7-H3 expression was scored positive in 38% (18 out of 48 tumors analysed), heterogeneous in 31% (15 out of 48 tumors analysed) and negative in 31% (15 out of 48 tumors analysed). This evidence concerns the gene CD276 and chondrosarcoma.